Structural heart disease is characterized by an abnormality in one or more components of the heart, such as valves, muscles, walls, septum, and major arteries. Several patients do not experience any symptoms. However, subtle fatigue and chest pain may be warning signs. The types of structural heart diseases are valve regurgitation, stenosis, septal defects, hypertrophic obstructive cardiomyopathy, and coarctation of the aorta.
Structural heart disease refers to various conditions affecting the valves, walls, chambers, or blood vessels of the heart. It may include abnormalities such as valve stenosis or regurgitation, congenital defects, or other structural problems.
Minimally Invasive Valve Replacement (MIVR) is a surgical procedure that involves replacing a damaged or diseased heart valve using smaller incisions compared to traditional open-heart surgery. This approach aims to minimize trauma and promote faster recovery times for patients.
Transcatheter Aortic Valve Intervention (TAVI), also known as Transcatheter Aortic Valve Replacement (TAVR), is a minimally invasive procedure used to treat aortic valve stenosis. It involves inserting a replacement valve through a catheter and implanting it within the diseased valve without removing the old one.
Transcatheter Mitral Edge-to-Edge Repair is a non-surgical technique used to treat mitral regurgitation by creating artificial leaflet coaptation in the mitral valve with clips inserted through catheters.
Transcatheter Tricuspid Edge-To-Edge Repair utilizes similar principles as mitral edge-to-edge repair but focuses on treating tricuspid regurgitation by improving leaflet closure at the tricuspid valve using specialized clips delivered via catheters.
Transcatheter Valve-in-Valve Implantation is a procedure performed to replace a failing bioprosthetic (tissue) valve with a new transcatheter valve. This technique avoids the need for open-heart surgery by inserting the new valve within the existing one using catheters.
Transcatheter Valve-in-MAC Implantation refers to placing a transcatheter valve inside a degenerated mitral annular calcification (MAC), which can obstruct normal valve function. This approach offers an alternative treatment option for patients who are not suitable candidates for traditional surgical interventions.
Medical Management of Valvular Heart Disease involves non-surgical approaches, such as medication and lifestyle modifications, aimed at managing symptoms and preventing disease progression in individuals with valvular heart conditions who may not require immediate intervention or are not suitable candidates for procedures.